-
-
Overview
-
Enzyme immunoassay for the quantitative determination of omalizumab (Xolair®) in serum and plasma. omalizumab ELISA has been especially developed for the quantitative analysis omalizumab in serum and plasma samples between the Cmin and Cmax range of concentrations indicated in the pharmacokinetics section of prospectus.
Please contact us at for specific academic pricing.
More Details
-
- Properties
- Applications
-
Overview